CVIR Oncology

Springer

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

CVIR Oncology is an open-access journal published by Springer in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,790 EUR. Declared review time at DOAJ: 19 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer
ISSN
3059-2003
Country
Switzerland
Languages
english
Access
Open access
Declared publication charge
1,790 EUR
Articles in DOAJ
15
Declared review time
19 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2026-07-13
Indexing
DOAJ
APC
1,790 EUR
Declared review time (DOAJ)
19 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

15

Most recent article

last month

Average review time (journal-declared via DOAJ)

19weeks

Works in OpenAlex

39

Last recorded publication year

2026

Reported by OpenAlex in 0 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

3

i10-index

0

From OpenAlex open data (CC0).

Editorial & policy11
Added to DOAJ
2026-07-13
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
98%
ORCID iDs in current deposits
81%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9919229123306676
Classification4

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogensMedicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine

LCC codes

RC254-282R895-920

Subject areas

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Medical Imaging Techniques and Applications
  • Renal cell carcinoma treatment
  • Ultrasound and Hyperthermia Applications
  • Renal cell carcinoma treatment
  • Radiopharmaceutical Chemistry and Applications
Show all subjects (75)
  • Renal cell carcinoma treatment
  • Lung Cancer Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Organ Transplantation Techniques and Outcomes
  • Microbial Inactivation Methods
  • Colorectal Cancer Treatments and Studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Advanced Radiotherapy Techniques
  • Bladder and Urothelial Cancer Treatments
  • Advanced Radiotherapy Techniques
  • Liver physiology and pathology
  • Advances in Oncology and Radiotherapy
  • MRI in cancer diagnosis
  • Advances in Oncology and Radiotherapy
  • Organ Transplantation Techniques and Outcomes
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Microbial Inactivation Methods
  • MRI in cancer diagnosis
  • Advances in Oncology and Radiotherapy
  • Ultrasound and Hyperthermia Applications
  • Liver Disease Diagnosis and Treatment
  • Microbial Inactivation Methods
  • Ultrasound and Hyperthermia Applications
  • Advanced X-ray and CT Imaging
  • Liver Disease and Transplantation
  • Advanced X-ray and CT Imaging
  • Vascular Anomalies and Treatments
  • Management of metastatic bone disease
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Medical Imaging and Pathology Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Management of metastatic bone disease
  • Intraperitoneal and Appendiceal Malignancies
  • Gallbladder and Bile Duct Disorders
  • Sarcoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Tuberous Sclerosis Complex Research
  • Radiology practices and education
  • Lung Cancer Diagnosis and Treatment
  • Economic and Financial Impacts of Cancer
  • Radiation Dose and Imaging
  • Lung Cancer Diagnosis and Treatment
  • Radiation Dose and Imaging
  • Lymphatic Disorders and Treatments
  • Vascular Anomalies and Treatments
  • Radiopharmaceutical Chemistry and Applications
  • Renal and related cancers
  • Management of metastatic bone disease
  • Artificial Intelligence in Healthcare and Education
  • Abdominal vascular conditions and treatments
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cardiac Arrhythmias and Treatments
  • Bone Tumor Diagnosis and Treatments
  • Radiation Dose and Imaging
  • Pulsed Power Technology Applications
  • Medical Image Segmentation Techniques
  • Renal and related cancers
  • Lymphatic Disorders and Treatments
  • Radiomics and Machine Learning in Medical Imaging
  • Tuberous Sclerosis Complex Research
  • Radiology practices and education
  • Radiopharmaceutical Chemistry and Applications
  • Anesthesia and Pain Management
  • Topic Modeling

Keywords (DOAJ)

  • interventional oncology
  • cancer care
  • interventional radiology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: